Edition:
United Kingdom

Coherus BioSciences Inc (CHRS.OQ)

CHRS.OQ on NASDAQ Stock Exchange Global Market

9.55USD
23 Feb 2018
Change (% chg)

$0.40 (+4.37%)
Prev Close
$9.15
Open
$9.25
Day's High
$9.60
Day's Low
$9.10
Volume
72,931
Avg. Vol
144,285
52-wk High
$26.55
52-wk Low
$8.07

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -1.091
Jun '17 1.39 -1.079
Mar '17 0.16 -1.535
FY 2016 Dec '16 0.84 -1.712
Sep '16 162.84 1.627
Jun '16 14.07 -1.719
Mar '16 12.36 -1.673
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 15.62
Quarter Ending Jun-18 1 0.00 0.00 0.00 16.30
Year Ending Dec-18 7 29.95 63.64 0.00 182.76
Earnings (per share)
Quarter Ending Mar-18 2 -0.57 -0.55 -0.59 --
Quarter Ending Jun-18 2 -0.58 -0.58 -0.59 --
Year Ending Dec-18 8 -2.77 -2.05 -4.02 -2.10
LT Growth Rate (%) 1 23.00 23.00 23.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -- 0.90 0.89
Price to Sales (TTM) 4.21 110.72 5.77
Price to Book (MRQ) 21.65 13.56 5.41
Price to Tangible Book (MRQ) 24.35 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions -- 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -90.08 398.34 9.24
Sales (TTM) vs TTM 1 Yr. Ago 277.32 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 37.25 25.10 19.66
EPS (TTM) vs TTM 1 Yr. Ago 59.07 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -- 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 4.27 5.30 2.97
LT Debt to Equity (MRQ) 313.99 22.82 12.22
Total Debt to Equity (MRQ) 313.99 24.47 16.52
Interest Coverage (TTM) -77.70 -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -69.10 -- --
EBITD - 5 Yr. Avg -- -572.68 10.86
Operating Margin (TTM) -71.35 -717.10 4.64
Operating Margin - 5 Yr. Avg. -- -594.00 6.26
Pre-Tax Margin (TTM) -74.03 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -- -597.35 6.60
Net Profit Margin (TTM) -74.03 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -- -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,087,072 22,602,130 855,673,508
Net Income/Employee (TTM) -804,763 2,968,748 100,656,226
Receivable Turnover (TTM) -- 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.78 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -57.79 -1.05 10.98
Return on Assets - 5 Yr. Avg. -- -0.57 12.37
Return on Investment (TTM) -86.92 1.66 14.43
Return on Investment - 5 Yr. Avg. -- 2.23 16.18
Return on Equity (TTM) -- 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 532.82 310.36 --
EPS (TTM) % 49.48 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Coherus BioSciences Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 94.94%
# of Holders: 165
Total Shares Held: 56,813,680
3 Mo. Net Change: 2,617,033
# New Positions: 18
# Closed Positions: 15
# Increased Positions: 64
# Reduced Positions: 54
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.